Speaker illustration

Doctor Gerard Linssen

Twente Hospital Group, Almelo (Netherlands (The))

Member of:

European Society of Cardiology
Heart Failure Association

Dr. Gerard Linssen, FESC, is a clinical cardiologist and staff member of a large general hospital in the Netherlands, collaborating as a teaching hospital with the Universities of Groningen and Twente. He was trained at the University Medical Center in Maastricht. His fields of interest are: heart failure, cardiovascular pharmotherapy, biomarkers, imaging, acute cardiac care. His research topics are heart failure management, clinical application of natriuretic peptides, atrial fibrillation, e-Health, telemonitoring, frailty, coronary stents. His PhD-thesis (University of Groningen, 2011): BNP and NT-proBNP in cardiovascular disease. Dr. Linssen and his teams publish in core medical journals. 2012 -2017: board member of the Dutch working group on Heart failure. He is actively involved in many randomized clinical trials. He acts as study director and former board member of the Dutch cardiovascular Research Network. He is national leader of PARAGON-HF, PARALLAX-HF and FINEARTS-HF studies.

Association between cardiovascular medication and readmission in heart failure patients

Event: Heart Failure 2019 - 6th World Congress on Acute Heart Failure

Topic: Treatment

Session: Rapid Fire 4 - Chronic heart failure - Pharmacology

Thumbnail

Association between heart failure medication at discharge and heart failure readmission

Event: Heart Failure 2019 - 6th World Congress on Acute Heart Failure

Topic: Treatment

Session: Moderated Poster Session - Chronic heart failure

Thumbnail

This platform is supported by

logo Novo Nordisk